Equities

BioSig Technologies Inc

BSGM:NAQ

BioSig Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.80
  • Today's Change-0.043 / -2.33%
  • Shares traded19.63k
  • 1 Year change-87.16%
  • Beta0.8191
Data delayed at least 15 minutes, as of May 22 2024 15:33 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BioSig Technologies, Inc. is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms. The Company’s product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is designed to pinpoint even the complex signals to maximize procedural success and efficiency. The PURE EP System is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time.

  • Revenue in USD (TTM)27.00k
  • Net income in USD-25.25m
  • Incorporated2011
  • Employees4.00
  • Location
    BioSig Technologies Inc55 Greens Farms RoadWESTPORT 06880United StatesUSA
  • Phone+1 (203) 409-5444
  • Fax+1 (302) 645-1280
  • Websitehttps://www.biosig.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
PAVmed Inc3.02m-71.05m17.35m107.00------5.75-9.08-9.080.3874-7.760.0588--64.1728,186.92-147.38-154.56---1,152.82-126.09---2,505.37-8,764.890.5301-8.321.82--550.40--25.76--55.51--
Orgenesis Inc529.00k-45.66m17.53m146.00------33.15-1.53-1.530.0174-0.80720.010149.690.0493,623.29-98.12---338.48---660.87---9,744.05--0.0662-12.23-----98.53-50.94-271.82---17.71--
Dalrada Financial Corporation32.16m-21.34m18.43m0.00--2.09--0.5732-0.2388-0.23880.35730.0911.098.863.37---75.10-80.63-239.06--30.1139.23-68.78-63.941.24-21.540.3452--54.35---43.94------
Meihua International Medical Tech Co Ltd97.10m11.63m19.34m617.001.560.12431.600.19920.48560.48564.066.110.578846.661.31157,372.606.9112.268.1315.0534.1938.1411.9415.475.21--0.04750.00-6.055.1086.22-5.56-9.16--
QT Imaging Holdings Inc0.00-4.02m19.51m----0.8973-----0.3999-0.39990.001.010.00-------12.32---16.60--------------0.3042-------45.07------
Agape ATP Corp1.37m-2.39m19.78m21.00--5.41--14.45-0.0312-0.03120.0180.04750.3949.4130.7965,188.57-68.48---94.72--64.84---173.78--4.99--0.0204---22.92---24.61------
Neuraxis Inc2.46m-14.63m20.11m17.00------8.18-3.78-3.780.5432------------------87.67---594.57-----23.75-----8.37---163.78------
SANUWAVE Health Inc22.41m-17.26m22.35m31.00------0.9973-0.0267-0.02670.0238-0.04171.103.607.50722,838.70-84.54-136.54----71.6369.13-77.00-189.600.11930.0192----21.8461.61-150.72------
BioSig Technologies Inc27.00k-25.25m22.96m4.00------850.24-3.24-3.240.0033-0.37760.008--1.746,750.00-728.65-269.73---363.1148.15---91,566.66-24,485.73---------93.71---6.52---9.58--
Ekso Bionics Holdings Inc17.91m-14.24m23.99m70.00--1.70--1.34-0.9685-0.96851.200.77650.54231.653.38255,900.00-43.11-43.63-57.86-57.6750.4151.93-79.48-104.242.11-34.630.2937--41.5710.03-0.7825--3.69--
Retractable Technologies Inc40.20m-7.80m27.39m148.00--0.2755--0.6815-0.2607-0.26071.343.330.21751.545.85271,589.10-4.1012.45-4.3014.5120.2540.82-18.8418.098.18-2.900.0145---54.025.55-249.46--17.42--
Femasys Inc1.05m-14.90m28.44m32.00--1.81--27.11-0.8567-0.85670.05880.70630.05490.49398.5832,785.00-77.93---86.46--65.35---1,420.27--8.02--0.3057---11.13---25.04------
Neuroone Medical Technologies Corp3.77m-12.80m28.62m16.00--7.10--7.60-0.5877-0.58770.16790.14640.5982.129.79235,460.60-203.24-172.88-269.30-274.7430.12---339.86-674.972.21--0.00--62.66---18.60------
Positron Corp1.24m-1.27m30.34m22.00------24.53-0.0897-0.08970.0876-0.11090.59762.296.56---61.35-224.13----32.989.85-102.67-201.870.0638-------10.060.275163.63--4.36--
SeaStar Medical Holding Corp0.00-33.67m30.60m12.00---------1.07-1.070.00-0.05930.00----0.00-605.20-----------------4.39---------115.19------
Data as of May 22 2024. Currency figures normalised to BioSig Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

3.66%Per cent of shares held by top holders
HolderShares% Held
PFG Investments LLCas of 31 Mar 2024106.15k0.95%
The Vanguard Group, Inc.as of 31 Mar 202468.79k0.61%
BlackRock Fund Advisorsas of 31 Mar 202459.55k0.53%
Geode Capital Management LLCas of 31 Mar 202456.76k0.51%
Jane Street Capital LLCas of 31 Mar 202443.82k0.39%
HRT Financial LLCas of 31 Mar 202426.33k0.24%
SSgA Funds Management, Inc.as of 31 Mar 202417.74k0.16%
Commonwealth Equity Services LLCas of 31 Mar 202412.50k0.11%
Truist Bank (Private Banking)as of 31 Mar 202411.23k0.10%
Tower Research Capital LLCas of 31 Mar 20247.05k0.06%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.